91 related articles for article (PubMed ID: 2445944)
1. Kinetic effects of adriamycin and bleomycin on two osteosarcoma models.
Bell DF; Bell RS; Mankin HJ; Gebhardt MC; Weltie F; O'Brien T
J Orthop Res; 1988; 6(1):51-7. PubMed ID: 2445944
[TBL] [Abstract][Full Text] [Related]
2. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
[TBL] [Abstract][Full Text] [Related]
3. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells.
Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M
Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of cytocidal and antitumor effect of cisplatin by caffeine in human osteosarcoma.
Tomita K; Tsuchiya H
Clin Ther; 1989; 11(1):43-52. PubMed ID: 2720727
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cytotoxic treatment of patients with osteosarcoma by an in vitro chemoresistance assay.
Agiostratidou G; Demertzis N; Gonos ES
Anticancer Res; 2000; 20(5B):3603-8. PubMed ID: 11131668
[TBL] [Abstract][Full Text] [Related]
6. Effects of ethane-1-hydroxy-1, 1 diphosphonate on Dunn osteosarcoma cells.
Kanamori M; Matsui H; Maeda A; Yudoh K; Tsuji H; Tatezaki S
J Exp Clin Cancer Res; 1997 Mar; 16(1):39-43. PubMed ID: 9148859
[TBL] [Abstract][Full Text] [Related]
7. Osteosarcoma cell apoptosis induced by selenium.
Hiraoka K; Komiya S; Hamada T; Zenmyo M; Inoue A
J Orthop Res; 2001 Sep; 19(5):809-14. PubMed ID: 11562125
[TBL] [Abstract][Full Text] [Related]
8. [Flow cytometric analysis of the effect of THP-adriamycin on the cell cycle traverse of RPMI-8402 cells--comparison with adriamycin].
Takamoto S; Ota K
Gan To Kagaku Ryoho; 1986 May; 13(5):1868-75. PubMed ID: 3707149
[TBL] [Abstract][Full Text] [Related]
9. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
[TBL] [Abstract][Full Text] [Related]
10. Cell kinetic changes in cultured tumor cells after treatment with radiation and chemotherapy.
Murata T; Akagi K; Uda M; Kimura H; Nasu R; Tanaka Y
Int J Oncol; 1998 Jan; 12(1):171-4. PubMed ID: 9454901
[TBL] [Abstract][Full Text] [Related]
11. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions.
Maher JC; Krishan A; Lampidis TJ
Cancer Chemother Pharmacol; 2004 Feb; 53(2):116-22. PubMed ID: 14605866
[TBL] [Abstract][Full Text] [Related]
12. Magnetic field induced inhibition of human osteosarcoma cells treated with adriamycin.
Chakkalakal DA; Mollner TJ; Bogard MR; Fritz ED; Novak JR; McGuire MH
Cancer Biochem Biophys; 1999 Jul; 17(1-2):89-98. PubMed ID: 10738905
[TBL] [Abstract][Full Text] [Related]
13. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients.
Pasello M; Hattinger CM; Stoico G; Manara MC; Benini S; Geroni C; Mercuri M; Scotlandi K; Picci P; Serra M
Eur J Cancer; 2005 Sep; 41(14):2184-95. PubMed ID: 16140527
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
[TBL] [Abstract][Full Text] [Related]
15. IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell lines.
Luk F; Yu Y; Walsh WR; Yang JL
Cancer Invest; 2011 Oct; 29(8):521-32. PubMed ID: 21843050
[TBL] [Abstract][Full Text] [Related]
16. Enhanced chemosensitivity of drug-resistant osteosarcoma cells by lentivirus-mediated Bcl-2 silencing.
Zhao Y; Zhang CL; Zeng BF; Wu XS; Gao TT; Oda Y
Biochem Biophys Res Commun; 2009 Dec; 390(3):642-7. PubMed ID: 19818735
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption.
Lamoureux F; Richard P; Wittrant Y; Battaglia S; Pilet P; Trichet V; Blanchard F; Gouin F; Pitard B; Heymann D; Redini F
Cancer Res; 2007 Aug; 67(15):7308-18. PubMed ID: 17671200
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of 1 alpha hydroxyvitamin D3 inhibits tumor growth and metastasis of a murine osteosarcoma model.
Hara K; Kusuzaki K; Takeshita H; Kuzuhara A; Tsuji Y; Ashihara T; Hirasawa Y
Anticancer Res; 2001; 21(1A):321-4. PubMed ID: 11299756
[TBL] [Abstract][Full Text] [Related]
19. Effect of human granulocyte macrophage-colony stimulating factor on differentiation and apoptosis of the human osteosarcoma cell line SaOS-2.
Postiglione L; Di Domenico G; Giordano-Lanza G; Ladogana P; Turano M; Castaldo C; Di Meglio F; Cocozza S; Montagnani S
Eur J Histochem; 2003; 47(4):309-16. PubMed ID: 14706926
[TBL] [Abstract][Full Text] [Related]
20. Alpha-tocopheryl succinate alters cell cycle distribution sensitising human osteosarcoma cells to methotrexate-induced apoptosis.
Alleva R; Benassi MS; Pazzaglia L; Tomasetti M; Gellert N; Borghi B; Neuzil J; Picci P
Cancer Lett; 2006 Feb; 232(2):226-35. PubMed ID: 16458119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]